WeVote

Bill

Bill

A 4767

Increases civil service credits given to veterans currently returning from service

2025 Regular Session Introduced by Karl Brabenec

The bill bans or limits regulated PFAS in menstrual products in New Jersey and creates a state testing, labeling, and enforcement system.

HELD FOR CONSIDERATION IN VETERANS' AFFAIRS
0
WeVote Research Nonpartisan
Bill Summary · A 4767

Summary — Assembly Bill A4767 (Swain / Haider, et al.)

Status: Introduced Sept. 19, 2024. Passed Assembly 78–0 (May 22, 2025). Reported out of Senate Commerce Committee with amendments (Nov. 17, 2025). Currently listed as HELD FOR CONSIDERATION IN VETERANS’ AFFAIRS. Companion: S3669.

Main purpose

A4767 would prohibit or limit the presence of regulated perfluoroalkyl and polyfluoroalkyl substances (PFAS) in menstrual products sold, distributed, or offered for use in New Jersey, and establish a State testing and enforcement regime to verify compliance.

Key provisions

  • Definitions
    • “Menstrual product” — products manufactured to catch menstruation or vaginal discharge (e.g., tampons, pads, discs, menstrual cups, underwear), including disposable and reusable items.
    • “Regulated PFAS” — as amended across versions, includes:
    • PFAS intentionally added to a product that provide a functional/technical effect (including PFAS components or intentional breakdown products); and
    • PFAS present above a measurable threshold as determined by total organic fluorine. (Threshold language changed during amendment history: initial drafts used 10 parts per million (ppm), a later amendment used 100 ppm, and the most recent committee amendment uses “above a technically unavoidable trace quantity.”)
  • Testing and laboratory oversight
    • The Department of Environmental Protection (DEP) must establish a system for manufacturers to periodically test products for regulated PFAS and approve laboratories to perform testing.
    • DEP must publish an online list of approved laboratories and acceptable testing methods (added in amendments).
    • Test results must be made available for inspection by the Department of Health (DOH), from either the manufacturer or the laboratory.
  • Enforcement and remedies
    • Violations are treated as unlawful practices under the New Jersey Consumer Fraud Act.
    • Monetary penalties provided: up to $10,000 for a first offense and up to $20,000 for subsequent offenses; Consumer Fraud Act remedies (cease-and-desist, punitive damages, treble damages and costs) also apply.
  • Effective date and administrative action
    • The act becomes effective approximately two years after enactment (varied slightly across drafts); DEP and DOH may take anticipatory administrative actions before the effective date.

Who is affected

  • Primary: manufacturers, distributors, and sellers of menstrual products (both disposable and reusable).
  • Secondary: testing laboratories (must seek DEP approval), DEP and DOH (implementation, inspection), Department of Law and Public Safety/Attorney General (enforcement), and consumers (potentially reduced PFAS exposure).

Fiscal and operational impacts

  • Office of Legislative Services (OLS) estimates indeterminate annual State expenditure and revenue increases.
    • DEP: one‑time costs to set up testing/approval system and publish lists.
    • DOH: ongoing costs if it inspects test results.
    • Law & Public Safety: enforcement costs; potential increase in revenue from assessed penalties (indeterminate).
  • OLS cannot quantify the number or amount of future penalties or enforcement costs.

Legislative history / sponsors

  • Sponsors/co-sponsors: Lisa Swain, Shama Haider, Garnet Hall (primary sponsors) and several co-sponsors (see bill text).
  • Related/prior-session bills listed; companion Senate bill S3669 reported with identical amendments on Nov. 17, 2025.

For details on exact threshold language, final text, or amendments, consult the latest reprint (3R) and committee reports.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.